骨质松丁/SPP1:在免疫细胞和血管化之间具有潜在的调解作用
Yanli Zhao1, Zujuan Huang1, Limei Gao1
1Department of Cardiovascular Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Frontiers in immunology
|June 26, 2024
概括
血管化涉及像巨细胞这样的免疫细胞. 分泌的蛋白1 (SPP1) 影响这些细胞,可能为血管化和心脏病提供新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 心血管生物学 心血管生物学
- 病理学 病理学 病理学
背景情况:
- 血管化 (VC) 是血管疾病中常见的病理过程,与心脏病中的炎症有关.
- 巨细胞,特别是SPP1+巨细胞,是VC的关键参与者,影响细胞因子的释放和囊泡的产生.
- 免疫细胞在动脉样硬化斑块中高度表达SPP1,促进斑块发育和化,但其在VC中的免疫细胞交叉需要进一步阐明.
研究的目的:
- 审查分泌蛋白1 (SPP1) 在血管化 (VC) 中的调节作用.
- 探索SPP1对免疫细胞的影响,包括T细胞,巨细胞和树突细胞,在不同器官的VC背景下.
- 确定SPP1作为管理VC的潜在治疗点.
主要方法:
- 文献综述侧重于研究SPP1,免疫细胞和血管化的研究.
- 对动脉样硬化斑块中的巨细胞和淋巴细胞功能研究的分析.
- 综合有关SPP1对VCT细胞,巨细胞和树突细胞的影响的研究结果.
主要成果:
- 在与血管化相关的炎症反应中,SPP1起着重要作用.
- 像巨细胞和SPP1表达的淋巴细胞这样的免疫细胞与动脉样硬化斑块和VC的进展有关.
- 在SPP1-介导的免疫反应和VC之间的交叉是关键的,但研究不足的方面.
结论:
- 通过对各种免疫细胞的影响,SPP1显著调节血管化.
- 了解SPP1在T细胞,巨细胞和树突细胞中的作用,可以了解VC机制.
- SPP1成为治疗血管化和相关心血管疾病的有希望的治疗标.
相关概念视频
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Role of Vitamins in Maintaining Bone Health
3.2K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.2K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K


